OPRX logo

OptimizeRx (OPRX) EBITDA

Annual EBITDA

-$21.31 M
-$11.04 M-107.51%

December 31, 2023

Summary

Performance

1-Year Change

-107.51%

3-Year Change

-35772.73%

5-Year Change

-2029.58%

15-Year Change

-1080.26%

OPRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.12%
OPRX annual EBITDA is higher than 50.12% of companies in Healthcare sector

High & Low

All-time High

$2.45 M
OPRX annual EBITDA is currently -970.58% below its historical high of $2.45 million

3-Year Low

-$21.31 M
OPRX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OPRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
OPRX next annual earnings announcement is scheduled for Mar 28, 2025

OtherOPRXprofitabilitymetrics:

Annual Revenue

$71.52 M
OPRX annual revenue is $71.52 million

Annual Net Income

-$17.57 M
OPRX annual net profit is -$17.57 million

Annual EBIT

-$23.71 M
OPRX annual earnings before interest & taxes is -$23.71 million

Annual EPS

-$1.03
OPRX annual earnings per share is -$1.03

Quarterly EBITDA

-$7.32 M
-$4.83 M-193.47%

September 30, 2024

Summary

Performance

3-Month Change

-193.47%

1-Year Change

-205.34%

3-Year Change

-749.46%

5-Year Change

-645.62%

OPRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.43%
OPRX quarterly EBITDA is higher than 41.43% of companies in Healthcare sector

High & Low

All-time High

$1.87 M
OPRX quarterly EBITDA is currently -491.87% below its historical high of $1.87 million

3-Year Low

-$9.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
OPRX next earnings announcement is scheduled for Mar 28, 2025

OtherOPRXprofitabilitymetrics:

Quarterly Revenue

$21.31 M
OPRX quarterly revenue is $21.31 million

Quarterly Net Income

-$9.12 M
OPRX quarterly net profit is -$9.12 million

Quarterly EBIT

-$8.42 M
OPRX quarterly earnings before interest & taxes is -$8.42 million

Quarterly EPS

-$0.50
OPRX quarterly earnings per share is -$0.50

TTM EBITDA

-$23.04 M
-$4.92 M-27.18%

September 30, 2024

Summary

Performance

3-Month Change

-27.18%

1-Year Change

-85.75%

3-Year Change

-1041.26%

5-Year Change

-1226.41%

OPRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.55%
OPRX TTM EBITDA is higher than 46.55% of companies in Healthcare sector

High & Low

All-time High

$3.19 M
OPRX TTM EBITDA is currently -822.50% below its historical high of $3.19 million

3-Year Low

-$23.04 M
OPRX TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
OPRX next earnings announcement is scheduled for Mar 28, 2025

OtherOPRXprofitabilitymetrics:

TTM Revenue

$88.18 M
OPRX TTM revenue is $88.18 million

TTM Net Income

-$24.17 M
OPRX TTM net profit is -$24.17 million

TTM EBIT

-$27.28 M
OPRX TTM earnings before interest & taxes is -$27.28 million

TTM EPS

-$1.34
OPRX TTM earnings per share is -$1.34

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$21.31 M
OPRX annual EBITDA is -$21.31 million

Annual Net Income

-$17.57 M
OPRX annual net profit is -$17.57 million

Annual Interest Expense

$1.45 M
OPRX annual interest expense is $1.45 million

Annual Income Tax

-$7.60 M
OPRX annual income tax is -$7.60 million

Annual D&A

$2.40 M
OPRX annual depreciation & amortization is $2.40 million

OPRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-107.5%-205.3%-85.8%
3 y3 years-10000.0%-749.5%-1041.3%
5 y5 years-2029.6%-645.6%-1226.4%

OPRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-970.6%at low-749.5%+21.1%-1041.3%at low
5 y5-year-970.6%at low-491.9%+21.1%-822.5%at low
alltimeall time-970.6%at low-491.9%+21.1%-822.5%at low

OptimizeRx EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.32 M(+193.5%)
-$23.04 M(+27.2%)
Jun 2024
-
-$2.50 M(-36.7%)
-$18.11 M(-6.1%)
Mar 2024
-
-$3.94 M(-57.5%)
-$19.28 M(-9.4%)
Dec 2023
-$21.31 M(+107.5%)
-$9.28 M(+287.0%)
-$21.27 M(+71.5%)
Sep 2023
-
-$2.40 M(-34.5%)
-$12.40 M(-6.4%)
Jun 2023
-
-$3.66 M(-38.3%)
-$13.25 M(+2.6%)
Mar 2023
-
-$5.93 M(+1355.1%)
-$12.91 M(+25.8%)
Dec 2022
-$10.27 M(-519.5%)
-$407.80 K(-87.4%)
-$10.27 M(+17.6%)
Sep 2022
-
-$3.24 M(-2.7%)
-$8.73 M(+77.2%)
Jun 2022
-
-$3.33 M(+1.2%)
-$4.93 M(+604.1%)
Mar 2022
-
-$3.29 M(-391.8%)
-$700.00 K(-128.6%)
Dec 2021
$2.45 M(-4220.5%)
$1.13 M(+99.8%)
$2.45 M(-23.2%)
Sep 2021
-
$564.20 K(-37.2%)
$3.19 M(+7.3%)
Jun 2021
-
$898.00 K(-732.4%)
$2.97 M(+93.2%)
Mar 2021
-
-$142.00 K(-107.6%)
$1.54 M(-2689.6%)
Dec 2020
-$59.40 K(-96.3%)
$1.87 M(+438.9%)
-$59.40 K(-98.0%)
Sep 2020
-
$346.70 K(-164.8%)
-$2.91 M(-40.9%)
Jun 2020
-
-$535.00 K(-69.2%)
-$4.92 M(+34.0%)
Mar 2020
-
-$1.74 M(+77.1%)
-$3.67 M(+111.5%)
Dec 2019
-$1.61 M(-245.9%)
-$982.00 K(-41.1%)
-$1.74 M(+951.4%)
Sep 2019
-
-$1.67 M(-333.0%)
-$165.20 K(-109.1%)
Jun 2019
-
$715.60 K(+263.6%)
$1.83 M(+27.0%)
Mar 2019
-
$196.80 K(-66.6%)
$1.44 M(+30.0%)
Dec 2018
$1.10 M(-161.2%)
$589.70 K(+82.5%)
$1.11 M(+202.9%)
Sep 2018
-
$323.20 K(-1.5%)
$365.20 K(-171.6%)
Jun 2018
-
$328.10 K(-343.6%)
-$509.80 K(-54.8%)
Mar 2018
-
-$134.70 K(-11.0%)
-$1.13 M(-37.5%)
Dec 2017
-$1.81 M(+38.5%)
-$151.40 K(-72.6%)
-$1.81 M(-6.2%)
Sep 2017
-
-$551.80 K(+89.9%)
-$1.93 M(+23.1%)
Jun 2017
-
-$290.50 K(-64.2%)
-$1.56 M(-13.8%)
Mar 2017
-
-$811.70 K(+198.9%)
-$1.81 M(+39.1%)
Dec 2016
-$1.30 M
-$271.60 K(+43.0%)
-$1.30 M(-3.8%)
Sep 2016
-
-$189.90 K(-64.9%)
-$1.35 M(+36.2%)
Jun 2016
-
-$540.90 K(+79.4%)
-$994.50 K(+87.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$301.50 K(-6.6%)
-$531.20 K(+103.4%)
Dec 2015
-$261.20 K(-65.7%)
-$322.70 K(-289.2%)
-$261.20 K(+944.8%)
Sep 2015
-
$170.60 K(-319.8%)
-$25.00 K(-94.1%)
Jun 2015
-
-$77.60 K(+146.3%)
-$423.90 K(-13.3%)
Mar 2015
-
-$31.50 K(-63.6%)
-$489.20 K(-35.7%)
Dec 2014
-$761.10 K(+935.5%)
-$86.50 K(-62.1%)
-$761.00 K(+51.4%)
Sep 2014
-
-$228.30 K(+59.8%)
-$502.70 K(+36.7%)
Jun 2014
-
-$142.90 K(-52.9%)
-$367.80 K(+378.9%)
Mar 2014
-
-$303.30 K(-276.5%)
-$76.80 K(-253.3%)
Dec 2013
-$73.50 K(-72.5%)
$171.80 K(-283.9%)
$50.10 K(-208.2%)
Sep 2013
-
-$93.40 K(-163.1%)
-$46.30 K(+279.5%)
Jun 2013
-
$148.10 K(-184.0%)
-$12.20 K(-93.6%)
Mar 2013
-
-$176.40 K(-334.0%)
-$189.20 K(-29.3%)
Dec 2012
-$267.30 K(-73.7%)
$75.40 K(-227.2%)
-$267.70 K(-29.8%)
Sep 2012
-
-$59.30 K(+105.2%)
-$381.10 K(-45.6%)
Jun 2012
-
-$28.90 K(-88.7%)
-$700.70 K(-34.0%)
Mar 2012
-
-$254.90 K(+570.8%)
-$1.06 M(+4.4%)
Dec 2011
-$1.02 M(-44.8%)
-$38.00 K(-90.0%)
-$1.02 M(-15.7%)
Sep 2011
-
-$378.90 K(-2.8%)
-$1.21 M(-8.9%)
Jun 2011
-
-$390.00 K(+85.8%)
-$1.32 M(-26.5%)
Mar 2011
-
-$209.90 K(-7.4%)
-$1.80 M(-2.4%)
Dec 2010
-$1.84 M(-59.3%)
-$226.70 K(-54.3%)
-$1.84 M(-53.2%)
Sep 2010
-
-$496.40 K(-42.7%)
-$3.94 M(-2.7%)
Jun 2010
-
-$866.60 K(+241.6%)
-$4.05 M(+15.2%)
Mar 2010
-
-$253.70 K(-89.1%)
-$3.52 M(-23.8%)
Dec 2009
-$4.52 M(+7.3%)
-$2.32 M(+283.7%)
-$4.61 M(-22.7%)
Sep 2009
-
-$605.30 K(+81.2%)
-$5.97 M(+8.2%)
Jun 2009
-
-$334.00 K(-75.3%)
-$5.51 M(+2.6%)
Mar 2009
-
-$1.35 M(-63.2%)
-$5.37 M(+27.1%)
Dec 2008
-$4.22 M(+1094.0%)
-$3.67 M(+2315.5%)
-$4.23 M(+666.3%)
Sep 2008
-
-$152.10 K(-20.7%)
-$551.40 K(+38.1%)
Jun 2008
-
-$191.70 K(-7.7%)
-$399.30 K(+92.3%)
Mar 2008
-
-$207.60 K
-$207.60 K
Dec 2007
-$353.10 K
-
-

FAQ

  • What is OptimizeRx annual EBITDA?
  • What is the all time high annual EBITDA for OptimizeRx?
  • What is OptimizeRx annual EBITDA year-on-year change?
  • What is OptimizeRx quarterly EBITDA?
  • What is the all time high quarterly EBITDA for OptimizeRx?
  • What is OptimizeRx quarterly EBITDA year-on-year change?
  • What is OptimizeRx TTM EBITDA?
  • What is the all time high TTM EBITDA for OptimizeRx?
  • What is OptimizeRx TTM EBITDA year-on-year change?

What is OptimizeRx annual EBITDA?

The current annual EBITDA of OPRX is -$21.31 M

What is the all time high annual EBITDA for OptimizeRx?

OptimizeRx all-time high annual EBITDA is $2.45 M

What is OptimizeRx annual EBITDA year-on-year change?

Over the past year, OPRX annual EBITDA has changed by -$11.04 M (-107.51%)

What is OptimizeRx quarterly EBITDA?

The current quarterly EBITDA of OPRX is -$7.32 M

What is the all time high quarterly EBITDA for OptimizeRx?

OptimizeRx all-time high quarterly EBITDA is $1.87 M

What is OptimizeRx quarterly EBITDA year-on-year change?

Over the past year, OPRX quarterly EBITDA has changed by -$4.92 M (-205.34%)

What is OptimizeRx TTM EBITDA?

The current TTM EBITDA of OPRX is -$23.04 M

What is the all time high TTM EBITDA for OptimizeRx?

OptimizeRx all-time high TTM EBITDA is $3.19 M

What is OptimizeRx TTM EBITDA year-on-year change?

Over the past year, OPRX TTM EBITDA has changed by -$10.64 M (-85.75%)